GERON CORP GERON ORD SHS - stock earnings
0IV3.L Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -44.8 million USD | 164000 USD |
| 2023Q2 | -49.2 million USD | 29000 USD |
| 2023Q1 | -38.1 million USD | 21000 USD |
| 2022Q4 | -42.6 million USD | 103000 USD |
| 2021Q3 | -26.7 million USD | 109000 USD |
| 2021Q2 | -29.6 million USD | 107000 USD |
| 2021Q1 | -27.8 million USD | 137000 USD |
| 2020Q4 | -23.8 million USD | 50000 USD |
| 2020Q3 | -19.7 million USD | 108000 USD |
0IV3.L Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -141.9 million USD | 596000 USD |
| 2021 | -116.1 million USD | 1.4 million USD |
| 2020 | -75.6 million USD | 253000 USD |
| 2019 | -68.5 million USD | 460000 USD |
| 2018 | -27.0 million USD | 1.1 million USD |
| 2017 | -27.9 million USD | 1.1 million USD |
| 2016 | -29.5 million USD | 6.2 million USD |
0IV3.L
Price: $3.80
52 week price:
Earnings Per Share: -0.36 USD
P/E Ratio: -6.47
Exchange: LSE
Sector: Healthcare
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Market Capitalization: 5.7 million